List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 56 studies with search of:   "Hemangiopericytoma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Trial of Dasatinib in Advanced Sarcomas
Conditions: MFH/Pleomorphic Undifferentiated Sarcoma;   Rhabdomyosarcoma;   Malignant Peripheral Nerve Sheath Tumors;   Osteosarcoma;   Chondrosarcoma;   Sarcoma, Ewing's;   Sarcoma, Alveolar Soft Part;   Chordoma;   Epithelioid Sarcoma;   Giant Cell Tumor of Bone;   Hemangiopericytoma;   Gastrointestinal Stromal Tumor (GIST)
Intervention: Drug: Dasatinib
2 Recruiting Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma
Conditions: CNS Cancer;   Meningioma;   Intracranial Hemangiopericytoma;   Hemangioblastoma;   Neurofibromatosis
Intervention: Drug: Sunitinib
3 Withdrawn Ifosfamide in Treating Patients With Meningeal Tumors
Conditions: Chondrosarcoma;   Adult Fibrosarcoma;   Adult Leiomyosarcoma;   Adult Rhabdomyosarcoma;   Adult Malignant Meningioma;   Adult Brain Malignant Hemangiopericytoma
Interventions: Drug: ifosfamide;   Procedure: chemotherapy
4 Recruiting Sunitinib in Treating Patients With Recurrent or Unresectable Meningioma, Intracranial Hemangiopericytoma, or Intracranial Hemangioblastoma
Conditions: Brain and Central Nervous System Tumors;   Neurofibromatosis Type 1 (nf1);   Neurofibromatosis Type 2 (nf2);   Precancerous/Nonmalignant Condition
Intervention: Drug: sunitinib malate
5 Active, not recruiting Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery
Conditions: Childhood Malignant Fibrous Histiocytoma of Bone;   Sarcoma
Interventions: Drug: celecoxib;   Procedure: adjuvant therapy;   Procedure: radiation therapy
6 Active, not recruiting Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma
Conditions: Brain and Central Nervous System Tumors;   Endometrial Cancer;   Gastrointestinal Stromal Tumor;   Ovarian Cancer;   Sarcoma;   Small Intestine Cancer
Intervention: Drug: trabectedin
7 Recruiting Monoclonal Antibody IMC-A12 and Doxorubicin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
Conditions: Adult Malignant Fibrous Histiocytoma of Bone;   Sarcoma
Interventions: Drug: cixutumumab;   Drug: doxorubicin hydrochloride
8 Completed Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Condition: Life Threatening Diseases
Intervention: Drug: Imatinib mesylate
9 Active, not recruiting Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: ifosfamide
10 Recruiting Temsirolimus With or Without Temozolomide in Treating Patients With Primary or Metastatic Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Drug: temsirolimus;   Procedure: observation
11 Active, not recruiting Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Ovarian Cancer;   Sarcoma
Intervention: Drug: temozolomide
12 Recruiting Radiation Therapy in Treating Patients Who Have Undergone Surgery for Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet
Condition: Sarcoma
Interventions: Procedure: adjuvant therapy;   Procedure: radiation therapy
13 Completed Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas
Conditions: Brain and Central Nervous System Tumors;   Breast Cancer;   Kidney Cancer;   Lung Cancer;   Lymphoma;   Melanoma (Skin);   Ovarian Cancer;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: carboxyamidotriazole;   Drug: paclitaxel
14 Completed Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Condition: Sarcoma
Intervention: Drug: soblidotin
15 Active, not recruiting Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
Condition: Sarcoma
Intervention: Drug: sorafenib tosylate
16 Recruiting Melphalan and Mannitol in Treating Patients With Central Nervous System Cancer
Conditions: Brain and Central Nervous System Tumors;   Chordoma;   Lymphoma;   Von Hippel-Lindau Syndrome
Interventions: Drug: mannitol;   Drug: melphalan
17 Recruiting Pazopanib in Treating Patients With Metastatic Soft Tissue Sarcoma That Has Relapsed or Not Responded to Treatment
Conditions: Endometrial Cancer;   Kidney Cancer;   Metastatic Cancer;   Ovarian Cancer;   Peripheral Nervous System Neoplasm;   Sarcoma;   Small Intestine Cancer
Interventions: Drug: pazopanib hydrochloride;   Drug: placebo
18 Recruiting Screening Patients With Central Nervous System Tumors for Participation in National Cancer Institute Clinical Trials
Conditions: Brain and Central Nervous System Tumors;   Lymphoma
Interventions: Procedure: cytology specimen collection procedure;   Procedure: physiologic testing
19 Recruiting PET Scan Combined With CT Scan in Predicting Response in Patients Undergoing Chemotherapy and Surgery for Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: fludeoxyglucose F 18;   Drug: ifosfamide;   Drug: pegfilgrastim;   Drug: pegylated liposomal doxorubicin hydrochloride;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
20 Completed Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: EF5;   Drug: fluorine F 18 EF5;   Procedure: conventional surgery;   Procedure: positron emission tomography

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services